HIVTransmission
Meeting category
Date(s)
10 Dec 2020 - 11 Dec 2020
Meeting type
Virtual Meeting

International Workshop on HIV Transmission 2020

Related Enduring Materials

Enduring Materials
Final Program

Day 1 - Thursday, 10 December 2020

Opening session - 9:00
9:00 EST
Welcome
Walid Heneine, PhD
Centers for Disease Control and Prevention, United States
Session 1: Ending The HIV Epidemic (EHE) in the US - 9:05
9:05 am
Introduction for Ending HIV Epidemic in the US: a Plan for America
9:15 am
Ending the HIV Epidemic: "Diagnose". The First Pillar of EHE
9:25 am
EHE in the U.S.: Treatment
Roy M. Gulick, MD, MPH
Weill Cornell Medicine / New York Presbyterian Hospital, United States
9:35 am
Research Needed to Expand the Use and Effectiveness of PrEP
9:45 am
Cluster Detection and Response
9:55 am
Abstract Driven Presentation: Evolving Trends in the Spread of HIV-1 in Quebec Among Men-Having-Sex-With-Men and New Migrants to Quebec (2002-2019)
Bluma Brenner
Lady Davis Institute, Canada
10:05 am
Abstract Driven Presentation: HIV Trace VS Phylogenetic Analysis: Unraveling Transmission Clusters in Spain
Federico García
Hospital Universitario San Cecilio, Spain
10:15 am
Abstract Driven Presentation: Dynamics of HIV-1 Transmission Clusters in North and Central Italy Over the Years 2012-2019
Rossana Scutari
University Of Rome Tor Vergata, Italy
10:25 am
Roundtable Discussion and Q/A With All Session Speakers
Session 2: Immune Mediated Prevention of HIV Transmission - 11:00
11:00 am
Vaccine Trials - What Went Wrong with the Vaccine Trial (HVTN 702)
Glenda E. Gray, MBBCH, FCPaeds (SA), DSc
South African Medical Research Council (SAMRC), South Africa
11:20 am
HIV Prevention and Monoclonal Antibodies
Myron S. Cohen, MD, BS
University of North Carolina at Chapel Hill, United States
11:40 am
Abstract Driven Presentation: Protection Against Repeated Intravenous Shiv Challenges by bNAb 10-1074 and 3BNC117
David Garber
CDC, USA
11:50 am
Abstract Driven Presentation: Broadly Neutralizing HIV-1 Antibody Reactivity in HIV Tests: Implications for Diagnostics
Tara Smith
CDC, USA
12:00 pm
Roundtable Discussion and Q/A With All Session Speakers

Day 2 - Friday, 11 December 2020

Session 3: Cellular Targets for Transmission - 9:05
9:05 am
Early Cellular Targets of HIV Infection
Anthony Cunningham, AO, FAHMS, MD, FRACP, FRCPA
The Westmead Institute for Medical Research, Australia
9:25 am
Mucosal Involvement in Transmission
Alexandra Schuetz, PhD
US Military HIV Research Program (MHRP), Thailand
9:45 am
Abstract Driven Presentations: Lactic Acid Produced by an Optimal Vaginal Microbiota Promotes Cervicovaginal Epithelial Barrier Integrity: Implications For HIV Transmission
Brianna Jesaveluk
Burnet Institute, Australia
9:55 am
Abstract Driven Presentation: Evaluation of Antiretroviral Drug Exposure in the Penile Compartment
Richard Haaland
CDC, USA
10:05 am
Roundtable Discussion and Q/A With All Session Speakers
Session 4: Animal Models for PrEP and Vaccine - 10:40
10:40 am
Macaque Modeling of Antiretroviral Prophylaxis for HIV Prevention
11:00 am
Potential Role for Tissue Resident Memory T Cells in a Protective Vaccine Against HIV
David Masopust, PhD
University of Minnesota Medical School, USA
11:20 am
Abstract driven presentations: Transmitted Drug Resistance to Integrase Based First-Line HIV Antiretroviral Treatment in the MeditRes HIV Collaboration
Federico García
Hospital Universitario San Cecilio, Spain
11:30 am
Abstract Driven Presentation: PK and PD Relationships of Vaginally Applied Integrase Inhibitors in Macaques
Kenji Nishiura
CDC, USA
11:40 am
Roundtable Discussion and Q/A With All Session Speakers
12:00 pm
Summary and Closure of Program
Walid Heneine, PhD
Centers for Disease Control and Prevention, United States
Overview
Welcome

Over the years, advances in HIV treatment have led to an enhanced understanding of the virus and improved care of HIV infected patients. However, our insights into the spread of the HIV virus remain limited. A more extensive exchange of knowledge on the various aspects of HIV transmission provides important outlooks for a better approach to the epidemic. For this purpose, an integrated forum was set up in 2006 to reveal the perspectives of experts from different fields, enabling discussion on all relevant mechanisms of HIV transmission. Since then the annual Transmission Workshops are valuable to those specialized (or specializing) in HIV transmission.

The main objective of this workshop is to provide a forum for basic scientists, clinicians, virologists, epidemiologists, and public health officials to present and to discuss the various aspects of the transmission of HIV. The ultimate goal of the workshop is the integration of efforts from all relevant disciplines in order to constrain the spread of (drug-resistant) HIV. We are sure that the workshop will help achieve this goal.

Chairs 2020

General Information 

Meeting Objectives
This workshop aims to:

- Enhance the integration of all relevant disciplines to constrain the spread of (drug-resistant) HIV; and

- Provide a forum to discuss the various aspects of the transmission of HIV.
Learning Objectives
After participating in this activity, participants will be able to:

- Get updated on the HIV epidemiological data in the US and public health strategies employed to bring the HIV epidemic to an end within 10 years;

- Reflect on the progress towards ending the HIV epidemic and identify remaining challenges in testing, treatment, and prevention including response to clusters of HIV infection in the US;

- Understand key challenges in the development of immune mediated prevention of HIV transmission;

- Reflect on the pros and cons of the technologies currently employed to develop immune mediated prevention;

- Identify differences between available animal models for HIV research;

- Reflect on limitations of animal models used in HIV research;

- Gain knowledge on mucosal involvement in HIV transmission; and

- Identify plausible targets for prevention.

Practical Information 

Certificate of Attendance
A digital certificate of attendance was sent to participants that successfully completed the workshop and post-meeting survey.
Language
The official language of the workshop was English. Translation was not provided.
Disclaimer
This workshop was intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agreed that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants were advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings were not permitted at the official workshop sessions. Only the official medical writer appointed by the organization could make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided that the speaker has given permission to do so.
Committees
Chairs 2020
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, they assist the Chairs by providing them with suggestions for speakers and topics. In addition, members of the Organizing Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Silver Level
Supporter level
Endorsers
Language
Sorry… This form is closed to new submissions.